Why Accelerant Holdings is on investors’ radar
Accelerant Holdings (ARX) has drawn attention after recent trading, with the stock closing at $15.91 and posting gains over the past week, month, and past 3 months that stand out in a mixed insurance sector.
See our latest analysis for Accelerant Holdings.
The recent 3.04% 1-day share price return and 51.81% 90-day share price return suggest strong short-term momentum, while the 1.92% year-to-date share price return paints a more measured longer-term picture.
If Accelerant’s move has your attention, it could be a good moment to broaden your watchlist and check out 18 top founder-led companies
With the stock up strongly over the past 3 months, annual revenue growth of 14.15% and a reported net loss of US$1,436.7m, the key question is whether Accelerant is undervalued today or if the market is already pricing in future growth.
Most Popular Narrative: 23% Undervalued
With Accelerant’s fair value estimate at $20.67 versus the last close at $15.91, the leading narrative sees meaningful upside grounded in a fee focused model.
Rapid expansion of specialized, small ticket commercial insurance products, supported by over 90 new offerings in the last 12 months and a record pipeline of more than $3 billion of annualized premium, is expected to support double digit exchange written premium growth and increase fee based revenue.
Want to see what is behind that growth pipeline and fee mix shift? The popular narrative leans on rising revenues, improving margins and a very punchy profit outlook, all compressed into one valuation story.
Result: Fair Value of $20.67 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there are clear pressure points here, including delays in shifting business to third party insurers and the risk that loss ratios move closer to industry levels.
Find out about the key risks to this Accelerant Holdings narrative.
Another view on valuation
The analyst narrative points to fair value of $20.67 and frames Accelerant as undervalued, but the current P/S ratio of 3.6x tells a different story. It is higher than the US Insurance industry average of 1.1x, peers at 1.5x, and even the fair ratio of 1.8x. This suggests valuation risk if sentiment shifts. So which signal matters more for you?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With sentiment divided between upside potential and valuation risk, it can be helpful to act quickly and review the full picture yourself. To see what optimistic investors are focusing on, start with the 1 key reward
Looking for more investment ideas?
If Accelerant has sparked your interest, do not stop here. Use the Simply Wall St screener to uncover other stocks that could fit your approach.
- Target stability and income potential by scanning for companies in the 12 dividend fortresses built for investors who want yield with resilience.
- Hunt for opportunities that the market may be overlooking by running your filters through the screener containing 21 high quality undiscovered gems before others catch on.
- Prioritize financial strength and resilience by focusing your search on the solid balance sheet and fundamentals stocks screener (45 results) so weaker options do not dilute your portfolio.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com